chr17-78124556-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127198.5(TMC6):​c.859G>A​(p.Val287Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00284 in 1,611,856 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 58 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 42 hom. )

Consequence

TMC6
NM_001127198.5 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -4.13

Publications

4 publications found
Variant links:
Genes affected
TMC6 (HGNC:18021): (transmembrane channel like 6) Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 10 transmembrane domains and 2 leucine zipper motifs. [provided by RefSeq, Jul 2008]
TMC6 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis, susceptibility to, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002837479).
BP6
Variant 17-78124556-C-T is Benign according to our data. Variant chr17-78124556-C-T is described in ClinVar as Benign. ClinVar VariationId is 456018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0527 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127198.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMC6
NM_001127198.5
MANE Select
c.859G>Ap.Val287Ile
missense
Exon 8 of 20NP_001120670.1
TMC6
NM_001321185.1
c.859G>Ap.Val287Ile
missense
Exon 8 of 20NP_001308114.1
TMC6
NM_001374596.1
c.859G>Ap.Val287Ile
missense
Exon 8 of 20NP_001361525.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMC6
ENST00000590602.6
TSL:2 MANE Select
c.859G>Ap.Val287Ile
missense
Exon 8 of 20ENSP00000465261.1
TMC6
ENST00000322914.7
TSL:1
c.859G>Ap.Val287Ile
missense
Exon 8 of 20ENSP00000313408.2
TMC6
ENST00000392467.7
TSL:1
c.859G>Ap.Val287Ile
missense
Exon 7 of 19ENSP00000376260.2

Frequencies

GnomAD3 genomes
AF:
0.0155
AC:
2359
AN:
152176
Hom.:
58
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0547
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00370
AC:
889
AN:
240366
AF XY:
0.00265
show subpopulations
Gnomad AFR exome
AF:
0.0561
Gnomad AMR exome
AF:
0.00205
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000559
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000121
Gnomad OTH exome
AF:
0.00153
GnomAD4 exome
AF:
0.00152
AC:
2215
AN:
1459562
Hom.:
42
Cov.:
33
AF XY:
0.00130
AC XY:
943
AN XY:
726122
show subpopulations
African (AFR)
AF:
0.0539
AC:
1802
AN:
33456
American (AMR)
AF:
0.00264
AC:
118
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86206
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51668
Middle Eastern (MID)
AF:
0.00158
AC:
9
AN:
5712
European-Non Finnish (NFE)
AF:
0.0000702
AC:
78
AN:
1111760
Other (OTH)
AF:
0.00330
AC:
199
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
147
294
440
587
734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0155
AC:
2363
AN:
152294
Hom.:
58
Cov.:
33
AF XY:
0.0147
AC XY:
1097
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0546
AC:
2269
AN:
41566
American (AMR)
AF:
0.00470
AC:
72
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68004
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
114
229
343
458
572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00272
Hom.:
9
Bravo
AF:
0.0178
ESP6500AA
AF:
0.0493
AC:
214
ESP6500EA
AF:
0.000238
AC:
2
ExAC
AF:
0.00466
AC:
562
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000594

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Epidermodysplasia verruciformis Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TMC6-related disorder Benign:1
Jul 11, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.0020
DANN
Benign
0.77
DEOGEN2
Benign
0.0088
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.057
N
LIST_S2
Benign
0.21
T
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PhyloP100
-4.1
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
0.11
N
REVEL
Benign
0.011
Sift
Benign
0.53
T
Sift4G
Benign
0.39
T
Polyphen
0.074
B
Vest4
0.11
MVP
0.030
MPC
0.13
ClinPred
0.0030
T
GERP RS
-7.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Varity_R
0.012
gMVP
0.22
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8078238; hg19: chr17-76120637; COSMIC: COSV59808961; COSMIC: COSV59808961; API